That Thursday, for the first time, the European Medicines Agency (EMA) approved a drug that targets the cause — not just the ...
The first drug targeting the root cause of Alzheimer’s disease has been approved by the European Medicines Agency. Despite ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...
Copyright 2024 The Associated Press. All Rights Reserved. FILE - A Coca-Cola sign is shown in San Francisco, Tuesday, Oct. 27, 2020. (AP Photo/Jeff Chiu,File) FILE ...
Biogen Inc. ( (BIIB)) has realeased its Q3 earnings. Here is a breakdown of the information Biogen Inc. presented to its investors. Biogen Inc. is a leading biotechnology company that specializes ...
Conservators in Florida spent seven months cleaning, drying and preserving two rare “onion bottles” that were likely made in England. Archaeologists were thrilled to discover the intact ...
At Bungalow, celebrity chef Vikas Khanna’s Indian restaurant in New York’s East Village, a dozen Indian single malt whiskies are spotlit in their own section on the spirits list. Just a few ...
Biogen’s investors are growing restless. Wednesday’s third-quarter earnings call checked most of the boxes for a successful report. The company raised its full-year ...
Despite a somewhat ambling launch, Biogen’s Eisai-partnered Alzheimer’s disease drug Leqembi continues to grow. But to truly unlock the amyloid-busting antibody’s potential, the company will ...
Biogen Raises Forecast as Alzheimer’s Drug Leqembi Shows Signs of Growth Quarterly Leqembi sales reached $67 million, beating estimates Cost cuts to drive high-teen percentage operating income boost ...
(Bloomberg) -- Biogen Inc. raised its annual earnings guidance after reporting better-than-expected third-quarter sales and profit, driven by ongoing cost-cutting measures and the strong performance ...
Biogen is the latest big biotech to make a play in protein degradation. The Massachusetts-based company has announced a deal to use Neomorph’s molecular glue degrader discovery platform to go ...